Lyell Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Arvinas and Agenus.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 1994 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations New Haven, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 188 | Employees 13329% increase | Employees 8174% decrease |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 1.9 b | Valuation ($) 96.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $114.2m (FY, 2025) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($80.8m) (FY, 2025) | Net income ($3.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 111.6m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View companyAgenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company